HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $729 | +16.6% | 13,917 | -9.5% | 0.00% | 0.0% |
| Q1 2024 | $625 | -1.4% | 15,374 | -10.4% | 0.00% | 0.0% |
| Q4 2023 | $634 | -90.1% | 17,167 | -89.3% | 0.00% | -81.2% |
| Q3 2023 | $6,429 | +805.5% | 159,761 | +712.0% | 0.02% | +433.3% |
| Q2 2023 | $710 | -5.5% | 19,674 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $751 | -32.9% | 19,674 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,119 | -99.9% | 19,674 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $778,000 | -10.2% | 19,674 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $866,000 | +10.3% | 19,674 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $785,000 | -11.9% | 19,674 | -11.2% | 0.00% | 0.0% |
| Q4 2021 | $891,000 | -1.1% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $901,000 | -10.4% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,006,000 | +9.0% | 22,149 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $923,000 | -2.4% | 22,149 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $946,000 | +34.8% | 22,149 | -17.1% | 0.01% | +25.0% |
| Q3 2020 | $702,000 | -2.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $716,000 | +48.9% | 26,722 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $481,000 | +1.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $474,000 | +14.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $414,000 | -9.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $459,000 | +6.7% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $430,000 | +10.0% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $391,000 | -19.5% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $486,000 | +7.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $451,000 | -13.8% | 26,722 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $523,000 | -7.8% | 26,722 | -4.6% | 0.00% | -25.0% |
| Q4 2017 | $567,000 | +16.7% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $486,000 | +35.4% | 27,999 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $359,000 | -1.1% | 27,999 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $363,000 | +31.0% | 27,999 | -0.0% | 0.00% | +50.0% |
| Q4 2016 | $277,000 | -18.0% | 28,013 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $338,000 | +39.7% | 28,013 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $242,000 | -8.7% | 28,013 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $265,000 | -44.8% | 28,013 | +1.0% | 0.00% | -50.0% |
| Q4 2015 | $480,000 | +165.2% | 27,723 | +106.2% | 0.00% | +100.0% |
| Q3 2015 | $181,000 | -40.5% | 13,444 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $304,000 | – | 13,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |